Aurobindo: US Tariffs “Not A Challenge” For Now, Scouting For Biosimilars Tie-Ups

“Entire” GLP-1 Range Including Semaglutide To Be Launched

 
• By Vibha Ravi
  
US Tariffs Are Leading To Fears Of Business Disruption
US Tariffs Are Leading To Fears Of Business Disruption (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from R&D